Skip to main content

Table 1 Baseline sample characteristics stratified by fentanyl exposure among OAT patients (n = 804)

From: The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting

Characteristic

UDS (for fentanyl)

p-value

Positive

n (%)

420 (52.2)

Negative

n (%)

384 (47.8)

Dissatisfaction

140 (33.3)

82 (21.4)

0.0001

Age (median, IQR)

42.8 (35.1–50.9)

51.5 (44.8–56.6)

 < .0001

Male gender

229 (54.5)

229 (59.6)

0.117

White

195 (46.4)

167 (43.5)

0.461

Homelessnessa

119 (28.3)

45 (11.7)

 < .0001

 ≥ Daily opioid usea, b

241 (57.4)

36 (9.4)

 < .0001

 ≥ Daily stimulant usea, b

128 (30.5)

98 (25.5)

0.119

Injection drug usea

378 (90)

221 (57.6)

 < .0001

  1. IQR interquartile range, OAT opioid agonist therapy, UDS urine drug screen
  2. aDenotes activities in the previous six months
  3. bRefers to any route of consumption (i.e., sniffing, snorting, smoking or injecting)
Back to article page

Addiction Science & Clinical Practice

ISSN: 1940-0640